Search research articles
Contact Us
Filters
Showing results (131-140 of 175) with videos related to
Page
of 18
Sort By:
European Urology
|
September 27, 2022
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
Gaëtan Devos, Lorenzo Tosco, Marcella Baldewijns, et al.
Molecular Cancer Research : MCR
|
January 27, 2022
Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer
Thomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
Molecular Cancer Therapeutics
|
July 24, 2023
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer
Justine Habault, Jeffrey A Schneider, Susan Ha, et al.
European Urology Oncology
|
August 15, 2019
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery
Thomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
Protein Science : a Publication of the Protein Society
|
March 21, 2024
Rational evolution for altering the ligand preference of estrogen receptor alpha
Roy Eerlings, Purvi Gupta, Xiao Yin Lee, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
June 10, 2022
A disease-associated missense mutation in CYP4F3 affects the metabolism of leukotriene B4 via disruption of electron transfer
Elien Smeets, Shengyun Huang, Xiao Yin Lee, et al.
European Urology Oncology
|
July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT Study
Daimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
European Urology Oncology
|
December 30, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)
Alexander Giesen, Gaëtan Devos, Lorenzo Tosco, et al.
Molecular Cancer Research : MCR
|
June 22, 2026
ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer
Francesca Lorenzin, Giulia Fracassi, Federico Vannuccini, et al.
The New England Journal of Medicine
|
November 2, 2012
Fracture risk and zoledronic acid therapy in men with osteoporosis
Steven Boonen, Jean-Yves Reginster, Jean-Marc Kaufman, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 175) with videos related to
Sort By:
Page
of 18
European Urology
|
September 27, 2022
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
Gaëtan Devos, Lorenzo Tosco, Marcella Baldewijns, et al.
Molecular Cancer Research : MCR
|
January 27, 2022
Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer
Thomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
Molecular Cancer Therapeutics
|
July 24, 2023
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer
Justine Habault, Jeffrey A Schneider, Susan Ha, et al.
European Urology Oncology
|
August 15, 2019
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery
Thomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
Protein Science : a Publication of the Protein Society
|
March 21, 2024
Rational evolution for altering the ligand preference of estrogen receptor alpha
Roy Eerlings, Purvi Gupta, Xiao Yin Lee, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
June 10, 2022
A disease-associated missense mutation in CYP4F3 affects the metabolism of leukotriene B4 via disruption of electron transfer
Elien Smeets, Shengyun Huang, Xiao Yin Lee, et al.
European Urology Oncology
|
July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT Study
Daimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
European Urology Oncology
|
December 30, 2025
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)
Alexander Giesen, Gaëtan Devos, Lorenzo Tosco, et al.
Molecular Cancer Research : MCR
|
June 22, 2026
ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer
Francesca Lorenzin, Giulia Fracassi, Federico Vannuccini, et al.
The New England Journal of Medicine
|
November 2, 2012
Fracture risk and zoledronic acid therapy in men with osteoporosis
Steven Boonen, Jean-Yves Reginster, Jean-Marc Kaufman, et al.
Page
of 18